Searched for
BOROSOFT
Reckitt Benckiser India to buy around 26% stake in Healthcare unit for Rs 725 croreReckitt Benckiser India plans to buy around 26% stake in its sister firm Reckitt Benckiser Healthcare for Rs 725 crore.- Shahs to drop Anchor's oral care portfolio; Emami close to buying toothpaste brandMumbai-based consumer products Anchor Healthcare has had several rounds of discussions with the Kolkata-headquartered Emami to sell its ora...
- Emami, Marico, Wipro eye Paras Pharma's Rs 100-crore personal care business from Reckitt BenckiserEmami, Marico and Wipro Consumer are in the final lap to acquire Paras Pharma's 100-crore personal care business from Reckitt Benckiser.
- Reckitt Benckiser CEO, Rakesh Kapoor comes to India alongwith board membersA Reckitt Benckiser spokeswoman confirmed that Kapoor was here on a "fixed agenda of internal business meetings".
- Emami to complete Rs 1,000 crore acquisition in 3 months: RS AgarwalEmami is in final stages of negotiations with a couple of target firms in India & abroad, including personal care biz of Paras Healthcare.
- Eyeing to buy Paras' personal care: EmamiEmami on Sunday said it is in talks with global FMCG giant Reckitt Benckiser to buy the personal care business of Paras Healthcare.
- Darshan Patel targets Paras Pharmaceuticals brandsDarshan Patel, the estranged brother of Paras Pharmaceuticals CMD Girish Patel, is set to take on brands such as DermiCool, ItchGuard and B...
- 30-something Generation Next that’s running the day-to-day show at Emami“When any acquisition is on the cards, we discuss what we’ll do if it happens - or even, as is far more likely, if it doesn’t happen. What ...
- Rivals may join hands for Paras buySome rival potential suitors of Ahmedabad-based Paras Pharmaceuticals are considering the option of co-bidding for the Rs 500-crore company...
- Too big to handleChandigarh based Checkmate International has the distinction of making chess pieces for Gary Kasparov’s signature brand and for upmarket re...
- Actis buys 23% in Paras PharmaActis has acquired shares from family members, as well as through a Rs 25-crore preferential allotment, industry sources told ET.
- Actis to buy 10% in Paras for Rs 100 crPrivate equity major Actis is close to picking up 10% in the Ahmedabad-based Paras Pharmaceuticals, the company that owns well known brands...
- Paras looks to buy int’l OTC brandsParas Pharmaceuticals iwants to acquire brands, or OTC companies, that would fit in with its growth plans.
Load More
